International Patent: METHODS AND COMPOSITIONS FOR TREATING OR REDUCING PMP22 GENETIC EXPRESSION IN PMP22-RELATED NEUROPATHY

GENEVA, July 6 -- TRANSCRIPTA BIO, INC. filed a patent application (US2025/059955) for “METHODS AND COMPOSITIONS FOR TREATING OR REDUCING PMP22 GENETIC EXPRESSION IN PMP22-RELATED NEUROPATHY”. With publication no. WO/2026/142892, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/277

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....